Newborn Screening for Congenital Heart Disease (NSCHD)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to test the accuracy of 7 indicators in screening congenital heart defects (CHD) in all newborns (symptomatic or asymptomatic) to determine whether these indicators could be applied in the nationwide newborn CHD screening. The investigator's hypothesis is that 7 indicators are effective in neonate CHD screening with the acceptable accuracy.
| Condition |
|---|
|
Congenital Heart Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Accuracy Assessment of 7 Clinical Indicators in Newborn Screening for Congenital Heart Disease |
- Diagnostic accuracy of the 7 indicators for detection of all CHDs and major CHDs [ Time Frame: The goldstandard for CHD diagnosis is the echocardiography performed within 1 hour from the screening completed. ] [ Designated as safety issue: No ]Sensitivity, specificity, negative and positive predictive value, negative and positive likelihood ratio of 7 indicators for the detection of all CHDs and major CHDs as gold standard the echocardiography.
| Estimated Enrollment: | 3000 |
| Study Start Date: | July 2012 |
| Estimated Study Completion Date: | October 2012 |
| Estimated Primary Completion Date: | September 2012 (Final data collection date for primary outcome measure) |
Congenital heart defects (CHD) are among the most common major congenital anomalies, and they occur worldwide with an incidence of about 8-12/1,000 live births , Most of these defects are mild or moderate. They either do not need treatment or treatment is needed only after infancy. Other defects are severe and require early treatment in infancy, which are the primary objectives of screening, because they are at risk of adverse or irreversible outcomes as a consequence of congenital heart defects. However, about half the neonates in the nursery have no distinctive clinical signs (symptoms, abnormal murmurs or cyanosis).So it's necessary to develop a screening strategy for neonatologist and pediatrician, especially physicians in community. Screening strategy in our study consists of 7 indicators: Family history of CHD, tachypnea, heart murmurs(≥ 2 grade), cyanosis, other non-cardiac malformations,special face feature(relating to chromosomal or non-chromosomal syndromes), subnormal Pulse Oximetry reading (Oxygen saturation of less than 95% in either limb or more than 3% difference)。The newborn babies with any of these 7 indicators positive will be considered positive-screened and echocardiography will performed.
The whole study (screening for CHDs with 7 indicators and performing the echocardiography for diagnosis) will be conducted by one single investigator (Quming Zhao from Children's Hospital of Fudan University). The new generation Pulse Oximetry has been proved to have low intraobserver and interobserver variability, but the interobserver variability in clinical evaluation (especially murmurs and cyanosis) remain unknown, the investigator will also assess the interobserver variability by comparing Quming Zhao and other two pediatricians (from the participating Hospital)(blind to each other).
Eligibility| Ages Eligible for Study: | up to 72 Hours |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
All consecutive neonates including pre-mature neonates and symptomatic neonates) will be recruited prospectively from two collaboration hospitals of the ongoing projects— "Key Clinical Research Project Sponsored by Ministry of Health Screening, evaluation and intervention of congenital heart disease in newborn infants(2010-239)"
Inclusion Criteria:
- all consecutive live newborn infants
- between 6-72hours of age
Exclusion Criteria:
- declining the screening;
- early discharge before the screening;
- missing
Contacts and Locations| Contact: Zhao Qu Ming, PHD | +86 13501878567 | jimmy517@126.com |
| China, Shanghai | |
| Songjiang District Central Hospital | Recruiting |
| ShangHai, Shanghai, China, 201620 | |
| Contact: Fan Z Rong, Master +86 18918288047 47907428@qq.com | |
| Principal Investigator: Zhao Qu Ming, PHD | |
| Songjiang Maternal and Child Health Hospital | Recruiting |
| Shanghai, Shanghai, China, 201620 | |
| Contact: Wang Ying, Master +86 18918282208 fbywangying@hotmail.com | |
| Principal Investigator: Zhao Qu Ming, PHD | |
| Study Chair: | Huang G Ying, MD PHD | Children's Hospital of Fudan University |
More Information
Publications:
| Responsible Party: | Guoying huang, President of Children's Hospital of Fudan University, Fudan University |
| ClinicalTrials.gov Identifier: | NCT01665261 History of Changes |
| Other Study ID Numbers: | KY2011-366-1 |
| Study First Received: | August 9, 2012 |
| Last Updated: | August 20, 2012 |
| Health Authority: | China: Ministry of Health |
Keywords provided by Fudan University:
|
Congenital heart disease Newborn Pulse oximetry Screening |
Additional relevant MeSH terms:
|
Heart Diseases Heart Defects, Congenital Cardiovascular Diseases Cardiovascular Abnormalities Congenital Abnormalities |
ClinicalTrials.gov processed this record on May 23, 2013